Get the Stockscreener App
10.66
15.13%
-1.90
After Hours:
10.4542
-0.2058
-1.93%
Why is Cabaletta Bio Inc (CABA) Stock down?
We've noticed a 15.13% decline in Cabaletta Bio Inc (CABA) stock during the 2024-06-14 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
28 Nov, 2023:
Cabaletta Bio Inc Stock (CABA) dropped by 26.79% from $18.70 to $13.69 in the trading on Tuesday November 28, 2023. The reason why CABA stock down today is due to FDA investigation into CAR-T therapy risks. The U.S. Food and Drug Administration (FDA) announcing an investigation into the potential risk of T-cell malignancies associated with BCMA- or CD19-directed autologous CAR-T cell immunotherapy treatments. Investors reacted to the FDA's investigation by selling off Cabaletta Bio stock, causing CABA's share price to plummet.
0.87%
0.21%
Cap:
|
Volume (24h):